⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002007219

Jones Ryan Alexander

Reports to the SEC for 1 company · EMERYVILLE, CA

Transactions

6

Companies

1

Filings

2

CIK

0002007219

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-11	KYTXKyverna Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+12K sh	—	—	55,950
2024-05-28	KYTXKyverna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+10.9K sh	$0.73	+$7,935.1	36,804
2024-05-28	KYTXKyverna Therapeutics, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,146 sh	$0.73	+$5,216.58	43,950
2024-05-28	KYTXKyverna Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−10.9K sh	—	—	0
2024-05-28	KYTXKyverna Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,146 sh	—	—	2,192
2024-04-11	KYTXKyverna Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+74K sh	—	—	74,000

Recent filings

2

Accepted (ET)
Apr 154
Jones Ryan Alexander0000950170-25-054344
SEC(opens sec.gov)
May 294
Jones Ryan Alexander0000950170-24-065983
SEC(opens sec.gov)

Companies

1

Kyverna Therapeutics, Inc.Chief Financial OfficerKYTX

Address

C/O KYVERNA THERAPEUTICS, INC. 5980 HORTON ST., STE 550

EMERYVILLE, CA, 94608